As of February 3, 2025, most of the Cal/OSHA’s COVID-19 Prevention Non-Emergency Regulations have formally come to an end, giving ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Most COVID-19 vaccines are injected into the arm or leg, and while they are effective at reducing illness and death, they do not halt transmission. The new trial will evaluate the safety and efficacy ...

Cal/OSHA’s non-emergency COVID-19 rule requiring employers to adopt measures to address COVID-19 hazards is set to expire on ...

According to the Centers for Disease Control, Mississippi is one of 20 states where COVID-19 infections are currently on the ...

LA Post shares insights from a UCLA study about Gen Z's desire for kindness and safety in the post COVID-19 world.

Best way to protect healthcare workers from COVID-19 and other infectious diseases is to complete Infectious Diseases rulemaking. On January 15, OSHA announced that it has terminated its COVID-19 ...

Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease ...

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...

The U.S. Labor Department's Occupational Safety and Health Administration on Jan. 15 terminated its COVID-19 healthcare rulemaking to prioritize completing a broader infectious diseases rule for ...

R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by Democratic senators during his confirmation hearing on Jan. 29, who ...